2-phenyl-indoles as prostaglandin D2 receptor antagonists

Details for Australian Patent Application No. 2006209213 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Nieduzak, Thaddeus R.; Jackson, Sharon; Harris, Keith J.; Yang, Zhaoxia; Mathew, Rose M.; Bordeau, Kenneth J.; Lang, Hans-Jochen; Shimshock, Stephen J.

Agent Watermark

Pub. Number AU-A-2006209213

PCT Pub. Number WO2006/081343

Priority 60/647,307 26.01.05 US

Filing date 25 January 2006

Wipo publication date 3 August 2006

International Classifications

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61K 31/405 (2006.01)

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 209/18 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/22 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/24 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/081343 Priority application(s): WO2006/081343

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006209216-Substituted arylamine compounds and their use as 5-HT6 modulators

2006209212-Controlled release compositions comprising an antipsychotic agent